Ryboquin raises £1.8m for drug development in gene therapy
This latest funding round attracts two prominent new investors; Brian Kennedy and Sir Brian Souter.
List view / Grid view
This latest funding round attracts two prominent new investors; Brian Kennedy and Sir Brian Souter.
A method to more accurately test anti-cancer drugs has now been developed at the Sahlgrenska Academy, University of Gothenburg.
For nearly two decades researchers have sought a way to target an oestrogen receptor in the hope they could improve breast cancer survival, but an article contends that the effort may never pan out.
A new scorpion-milking robot designed to extract venom could replace the traditional manual method.
University of Warwick expertise is contributing to a world-first £1.5million study aiming to tackle one of the biggest public health threats we face - antibiotic resistance.
The wealth of data produced by the European Commission's Joint Research Centre (JRC) is now available to external users.
A mixed reality system which allows medical practitioners to view and interact with virtual replicas of patients’ organs, bones or body parts is being developed by academics.
For many bowel cancer patients, following the initial shock of their diagnosis, thoughts quickly turn to estimating how much time they have to live...
BioGeneration Ventures (BGV) announces an investment by the European Investment Fund (EIF) and other new investors in BGV III...
Research has yielded the first successful isolation and maintenance of haploid embryonic stem cells in humans.
Long-term goal is to develop treatments that prevent cancer cells from attaching to new sites during metastasis.
UC biologist helps decode the structural complexities of male butterfly ejaculate and co-evolving female reproductive tract. Findings from these biochemical relationships may help unlock certain mysteries of human infertility
Researchers from the Cornell University College of Veterinary Medicine, New York, have discovered a key metabolic mechanism in Mycobacterium tuberculosis (Mtb) bacteria, which presents as a novel drug target for potentially treating tuberculosis.
LifeArc, the UK medical research charity previously known as MRC Technology; The Centre for Drug Research and Development (CDRD); and the Defence Science and Technology Laboratory (Dstl), have announced a collaboration to identify antibacterial drug targets.
Women who receive human papillomavirus (HPV) testing, in addition to a Pap smear, receive a faster, more complete diagnosis of possible cervical pre-cancer, according to a study of over 450,000 women by Queen Mary University of London (QMUL) and the University of New Mexico (UNM) Comprehensive Cancer Center.